Showing results (31-40 of 93) with videos related to
Sort By:
Pageof 10
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classificationMark E Sherman, Brigitte M Ronnett, Olga B Ioffe, et al.Journal of Medical Economics|June 8, 2021
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US - updated analyses with additional trial follow-upRalph P Insinga, Josephine L Feliciano, Nan Qiao, et al.Rheumatology and Therapy|April 11, 2018
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in ScotlandRebekah H Borse, Sumesh Kachroo, Chloe Brown, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United StatesRalph P Insinga, Kai-Li Liaw, Lisa G Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasiaJames V Lacey, Mark E Sherman, Brenda B Rush, et al.Lancet (London, England)|July 23, 2002
Viral load of human papillomavirus and risk of CIN3 or cervical cancerAttila T Lorincz, Philip E Castle, Mark E Sherman, et al.Journal of Clinical Microbiology|August 19, 2007
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesionsPatti E Gravitt, Leen Jan van Doorn, Wim Quint, et al.Current Medical Research and Opinion|July 30, 2008
Five-year routine cervical cancer screening rates and intervals in a US health planVernon F Schabert, Xin Ye, Ralph P Insinga, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Age-based programs for vaccination against HPVElamin H Elbasha, Erik J Dasbach, Ralph P Insinga, et al.Journal of General Internal Medicine|July 30, 2005
The incidence of herpes zoster in a United States administrative databaseRalph P Insinga, Robbin F Itzler, James M Pellissier, et al.Pageof 10